AusCann Group Holdings Ltd (AC8, formerly TW Holdings Limited) is into developing a differentiated portfolio of innovative and standardised cannabinoid based medicines that expands the therapeutic applications of cannabis, offering both people and pets greater benefit for the treatment of inadequately met medical needs.